Attorney General Raoul Petitions FDA To Remove Burdensome Restrictions On Mifepristone
CHICAGO – Attorney General Kwame Raoul, as part of a coalition of 17 attorneys general and the Commonwealth of Pennsylvania, today called on the U.S. Food and Drug Administration (FDA) to remove burdensome restrictions on mifepristone, one of two drugs used in medication abortions. Raoul and the coalition submitted a filing presenting extensive evidence on the safety of medication abortion in their states as well as the burdens imposed by the FDA’s continued restrictions on mifepristone. In today’s filing (attached), Raoul and the coalition join and supplement a citizen petition filed with the FDA by Massachusetts, California, New Jersey and New York on June 5, urging the agency to eliminate unnecessary restrictions on this safe medication that make it much harder for patients to access medication abortions, particularly in rural and medically underserved areas. “The existing restrictions on mifepristone only serve to create unnecessary obstacles for patients